08-01-2009

Dergi Hakkında
Sayı Editörü'nden
Bu Sayının Yazarları
Geçmiş-Gelecek Sayılar
Yazım Kuralları
Yayın Hakları Devir Formu
Online Makale İşlemleri
İletişim
Üroloji Dergisi
ISSN: 1305-3876
Hakkında: Özel sayılar şeklinde yayınlanır.

 
Update On Outcomes Research Databases In Prostate Cancer 2006

Dr. Stephen J. FREEDLAND, Dr. Tracey L. KRUPSKI, Dr. Judd W. MOUL

Department of Surgery, Division of Urology, bDepartment of Pathology, Duke University School of Medicine, Durham, North Carolina, USA



Purpose of Review: The purpose of this review is to summarize singleinstitution prostate-cancer-outcomes databases (which are most commonly derived from large academic medical centers, Veterans Affairs medical centers, and military hospitals) to summarize the design and development of three well character-ized outcomes databases that combine data from multiple sites (Carcinoma of the Prostate Strategic Urological Research Endeavor, Center for Prostate Disease Research, and the Shared Equal Access Regional Cancer Hospital database) and to use the examples of obesity and prostate-specific antigen changes over time to highlight the importance of these databases in prostate-cancer outcomes.
Recent Findings: Multiple databases have demonstrated that obese men are at greater risk of biochemical progression following radical prostatectomy. In addition, objective data have shown that it is more difficult to operate on obese men leading to greater risk of positive surgical margins, which may contribute to poorer outcomes. Several databases have shown that a rap-idly increasing prostate-specific antigen, measured either before diagnosis or after failed primary therapy, is associated with increased risk of prostate-cancer-specific mortality.
Summary: Outcomes databases are extremely useful tools. They have lead to dramatic improvements of our understanding of prostate cancer. The challenge is to use this information from past patients to help us better manage our current and future patients.


Keywords: Databases, obesity, outcomes, prostate cancer, prostatespecific antigen, PSA doubling time

Turkiye Klinikleri J Surg Med Sci 2006, 2(38):48-52

E-mail To Friend This Page Printer Friendly Page
 
 
 ARAMA
  
 Ayrıntılı Arama
 GİRİŞ
 Kullanıcı Adı :
 
 Şifre  
   Beni Hatırla
 Şifremi Unuttum
 Kayıt Ol
 
 
 
 
 
 
 
 

Yasal uyarı: Bu sitede yayınlanan resim, yazı ve diğer uygulamaların her hakkı Ortadoğu Reklam Ve Yayıncılık A.Ş. 'ye aittir. Kaynak gösterilmeden kullanılamaz. Bu site hekimleri sağlık alanında bilgilendirmeye yönelik hazırlanmıştır. Sitede yer alan bilgiler tanı ve tedavi amaçlı kullanıldığında sorumluluk tamamen kullanıcıya aittir. Siteye girmekle bu şartları okumuş, anlamış ve kabul etmiş sayılırsınız.